Efficacia e sicurezza di tenecteplase in associazione con enoxaparina, abciximab o eparina non frazionata nell'infarto miocardico acuto: Risultati dello studio ASSENT-3

Translated title of the contribution: The Assessment of the Safety and Efficacy of a New Thrombolytic regimen (ASSENT-3) investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial infarction

Research output: Contribution to journalArticle

Translated title of the contributionThe Assessment of the Safety and Efficacy of a New Thrombolytic regimen (ASSENT-3) investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial infarction
Original languageItalian
Pages (from-to)245-246
Number of pages2
JournalItalian Heart Journal Supplement
Volume3
Issue number2
Publication statusPublished - 2002

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this